Clinical Trial: Efficacy and Safety of Da-Cheng-Qi Decoction in Severe Acute Pancreatitis

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07816900) titled 'Efficacy and Safety of Da-Cheng-Qi Decoction in Severe Acute Pancreatitis' on Sept. 08.

Brief Summary: This single-center prospective randomized controlled trial evaluated Da-Cheng-Qi Decoction (DCQD) as the acute-stage intervention of an integrated traditional Chinese and Western medicine whole-stage treatment protocol for severe acute pancreatitis (SAP). Sixty adults with SAP and intra-abdominal hypertension (IAP >= 12 mmHg) were randomized within 72 h of onset to receive standard Western treatment plus DCQD (100 mL via nasogastric tube twice daily for 7 days) or standard Western treatment alone. The primary outcome was intra-abd...